- Spruce Biosciences Recognized as a Bay Area Best Place to Work
- Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
- Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
- Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
- Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
- Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
- Spruce Biosciences to Participate in May Investor Conferences
- Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
More ▼
Key statistics
On Wednesday, Spruce Biosciences Inc (SPRB:NSQ) closed at 0.5424, 7.83% above its 52-week low of 0.5030, set on Jun 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.5288 |
---|---|
High | 0.5649 |
Low | 0.526 |
Bid | 0.5469 |
Offer | 0.5499 |
Previous close | 0.5424 |
Average volume | 484.66k |
---|---|
Shares outstanding | 41.15m |
Free float | 37.96m |
P/E (TTM) | -- |
Market cap | 22.32m USD |
EPS (TTM) | -1.15 USD |
Data delayed at least 15 minutes, as of Jul 24 2024 20:59 BST.
More ▼